Henry Schein HSIC Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Henry Schein in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Henry Schein’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Henry Schein's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Henry Schein's cash & equivalents?
- Henry Schein (HSIC) reported cash & equivalents of $138M in Q1 2026.
- How has Henry Schein's cash & equivalents changed year-over-year?
- Henry Schein's cash & equivalents increased by 8.7% year-over-year, from $127M to $138M.
- What is the long-term trend for Henry Schein's cash & equivalents?
- Over 5 years (2020 to 2025), Henry Schein's cash & equivalents has grown at a -18.0% compound annual growth rate (CAGR), from $421M to $156M.
- What does cash & equivalents mean?
- The total value of cash and highly liquid investments that can be accessed immediately.
- How do you interpret cash & equivalents?
- An increase suggests strong liquidity and potential for acquisitions or debt reduction, while a decrease may indicate heavy capital expenditure or operational cash burn.
- How does cash & equivalents compare across companies?
- Peers in healthcare distribution typically maintain moderate cash balances to balance liquidity needs with capital efficiency.